IRVINE, CA--(Marketwire - Mar 29, 2012) - Enterey Life Sciences Consulting, a leading provider of consulting services focused on manufacturing and quality operations for life sciences companies, credits senior consultant with saving a client as much as $3 million annually.
Enterey's senior consultant was tasked with supporting the technology transfer process for a top-tier biotech, which included moving manufacturing operations from the previous clinical facility to a new, fully commercialized facility. The consultant's main priorities were to ensure that manufacturing requirements were met, as well as to manage the impact assessment and implementation plan processes. In addition, the consultant conducted utilization and spend analyses, resulting in millions of dollars of savings.
First, the consultant drilled down into the client's overall spend and highlighted areas where the client could save money.
"To put it simply," explains the consultant, "I looked at the manufacturing spend and informed the client that there were things they were paying a dollar for, when they could get the same items for a dime instead. I then presented the data to the client's procurement department, creating the potential for millions of dollars in savings."
"Spend analysis like this is the foundation of a robust procurement program," according to Gregg Brandyberry, former Vice President of Procurement, Global Systems and Operations at GlaxoSmithKline and former Senior Advisor, A.T. Kearny Procurement and Analytic Solutions, "and combined with procurement best practices, spend analytics can result in overall savings of 10 to 30 percent."
Second, the Enterey consultant developed a tool for the client that allowed employee utilization rates to nearly double.
"Because production for this client is highly specialized and has a lightning-fast turnaround time, I wanted to develop a way to very quickly analyze how many employees are needed at a given time based on incoming materials," says the Enterey consultant. "Whereas employees were working five eight-hour shifts, I found that they should be working three 12-hour shifts instead, and these changes will take the utilization rate from roughly 50 percent up to as much as 90 percent."
According to Enterey CEO Mike Ferletic, "Establishing tools to analyze spend and resource utilization will not only save significant investment, but will also provide a means to proactively evaluate future changes to production when demand changes," and, he says, "these tools give insight as to how to handle those changes."
Enterey Life Sciences Consulting, founded in 2002, provides life sciences consulting expertise in both process- and systems-related projects for biotech, medical device, and pharmaceutical clients. Enterey provides solutions ranging from strategic planning to business-integration, and has a proven track record of success supporting both clinical and commercial facility start-ups.
For information about Enterey, visit: http://www.enterey.com or call (800) 691-2349.